Ghrelin control of GH secretion and feeding behaviour: the role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands.
Energy homeostasis is controlled by a complex regulatory system of molecules that affect food intake and that are critical for maintaining a stable body weight during life. Ghrelin is a peptide of 28 amino acid synthesized predominantly by the stomach and the gut, which activate the type 1a growth hormone (GH) secretagogue receptor (GHS-R1a), a G-protein coupled receptor. The acylated form of ghrelin potently stimulates GH secretion both in vitro and in vivo in several animal species, including humans. Beside the endocrine effect, ghrelin shows also extraendocrine activities, including stimulation of feeding behaviour. Several classes of small synthetic peptide and non-peptide ligands of the GHS-R1a have been described and are able to release GH and stimulate food intake. However, in time, it appeared that the stimulating effects on GH secretion could be divorced from those on food intake, suggesting that more than a single receptor might be involved. Several experimental data have even questioned the physiological role of ghrelin in the control of GH secretion and energy metabolism. By using novel agonists, partial agonists, and antagonists for the GHS-R1a receptor, we have studied whether the stimulation of this receptor could account for the purported physiological role of ghrelin. Our results demonstrate that the ability to bind in vitro the GHS-R1a is not predictive of the in vivo biological activity of the compounds and that the endocrine and extraendocrine effects could be mediated also by receptors different from the GHS-R1a.
Bresciani
E
E
Department of Experimental Medicine, University of Milano-Bicocca, 20052 Monza, Italy.
Tamiazzo
L
L
Torsello
A
A
Bulgarelli
I
I
Rapetti
D
D
Caporali
S
S
Perrissoud
D
D
Moulin
A
A
Fehrentz
J A
JA
Martinez
J
J
Locatelli
V
V
D000704:Analysis of Variance; D000818:Animals; D004734:Energy Metabolism; D005247:Feeding Behavior / Q000502:physiology*; D054439:Ghrelin / Q000378:metabolism / Q000502:physiology*; D013006:Growth Hormone / Q000378:metabolism*; D006706:Homeostasis; D019382:Human Growth Hormone / Q000378:metabolism*; D006801:Humans; D051381:Rats; D017207:Rats, Sprague-Dawley; D043562:Receptors, G-Protein-Coupled / Q000037:antagonists & inhibitors / Q000378:metabolism; D054440:Receptors, Ghrelin / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology; D014230:Triazoles / Q000008:administration & dosage / Q000009:adverse effects*
D054439:Ghrelin; D043562:Receptors, G-Protein-Coupled; D054440:Receptors, Ghrelin; D014230:Triazoles; D019382:Human Growth Hormone; D013006:Growth Hormone